Claris Lifesciences gets supplemental ANDA for Fluconazole Injection in 50 ml PVC bags

In United States

Claris Lifesciences announced that it has received supplemental abbreviated new drug application (ANDA) approval for Fluconazole Injection in the United States. The Company currently markets Fluconazole in 2mg/ ml formulation packed in 100ml and 200ml PVC bags and now with the approval of supplemental ANDA, Claris is the only company to be able to sell Fluconazole in 50 ml variant in the US.

Powered by Capital Market - Live News